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Clinics, 600 Highland Ave, Madison, WI 53792, USAAlthough most patients with alcoholic liver disease experience the severest forms of alcoholic hepatitis have not been offered
positive outcomes following liver transplantation, data on the
outcome after liver transplantation in patients with severe alco-
holic hepatitis are limited. Furthermore, predicting which
patients with severe alcoholic hepatitis will maintain sobriety
after transplantation is especially difﬁcult. We review the argu-
ments in favour and against extending liver transplantation to
selected patients with severe alcoholic hepatitis. In conclusion,
we propose that liver transplantation should be a rescue option
for occasional patients with severe alcoholic hepatitis who meet
the following criteria: those with severe alcoholic hepatitis that
has failed medical management, who fulﬁl all other standard cri-
teria for transplantation, including a thorough psychosocial
assessment, yet who are unlikely to survive a mandatory 6-
month abstinence period.
 2010 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.Introduction
Alcoholic hepatitis is a clinical syndrome occurring in persons
who have been drinking excessively, usually for many years [1].
Alcoholic hepatitis presents as new onset jaundice, accompanied
by fever, ascites, cachexia, and tender hepatomegaly. The clinical
syndrome is accompanied by a pattern of laboratory tests, in
which serum aspartate aminotransferase is elevated and exceeds
serum alanine aminotransferase, and the peripheral leukocyte
count is elevated, as well as by characteristic pathologic ﬁndings,
including Mallory bodies, ballooned hepatocytes, steatosis, and
pericellular ﬁbrosis. The initial evaluation needs to rule out co-
morbid bacterial infection. Abstinence from all alcohol is the
key to recovery from alcoholic hepatitis. However, alcoholic hep-
atitis represents a spectrum of clinical severity, and the outcome
for patients who manifest the most disturbed liver function is
poor and early death is common, even in those patients who
abstain from alcohol.
Despite its high mortality, and the potential for liver trans-
plantation as a rescue intervention, heretofore, patients withJournal of Hepatology 20
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about treating alcoholic liver disease. However, in the past
20 years, alcoholic cirrhosis has become one of the most common
indications for liver transplantation, albeit only after a careful
selection of candidates. A similar evolution of thought has not
occurred regarding the treatment of alcoholic hepatitis by liver
transplantation, and liver transplantation has not become the
rescue treatment of choice in patients with life-threatening alco-
holic hepatitis.
To review the development of attitudes regarding liver trans-
plantation in the treatment of severe alcoholic hepatitis, it is
informative to return to 1997 when the American Society of
Transplantation and the American Association for the Study of
Liver Diseases held a conference to determine minimal criteria
for the placement of adults on the waiting list for liver transplan-
tation [2]. The participants concluded that whereas the minimal
listing criteria to be used for ‘patients with chronic parenchymal
liver disease should apply to patients with alcoholic liver disease
also’, they stated that ‘there is a strong consensus for requiring
that most alcoholic patients should be abstinent from alcohol
for at least 6 months before they can be listed for liver transplan-
tation’. The report recognised that ‘the 6 month abstinence
requirement, in effect, excludes patients with alcoholic hepatitis
from consideration for liver transplantation.’ Similarly, liver
transplantation units in the UK deem alcoholic hepatitis as a con-
traindication to LT [3]. The purpose of the present paper is to
reconsider whether this interdiction against placing patients with
alcoholic hepatitis on the liver transplant waiting list should be
revised, in light of the changes in our understanding of the prog-
nosis and management of severe alcoholic hepatitis.Medical management is efﬁcacious for severe alcoholic
hepatitis
Since 1997, the most important development in the management
of severe alcoholic hepatitis has been the greater understanding
of the use of prednisolone. Severe alcoholic hepatitis can be
deﬁned by prognostic instruments based on clinical data such
as the Maddrey discriminant function (DF), the model for end-
stage liver disease (MELD) score, and the Glasgow alcoholic hep-
atitis score (see Table 1). Prednisolone should be restricted to
patients without systemic infection who have a Maddrey DF of10 vol. 52 j 759–764
Table 1. Scoring systems to assess prognosis in alcoholic hepatitis (adapted from ref:).
Billirubin PT or INR Creatinine Age WCC
(109/L)*
Urea
(mmol/L)
Albumin
(g/L)
Evolution in billirubin
between day 0 and day 7**
DF + + NA NA NA NA NA NA
MELD + + + NA NA NA NA NA
Glasgow + + NA + + + NA NA
Lille + + + + NA NA + +
Discriminant Function (DF) = 4.6 (prothrombin time [seconds]  control time seconds) + serum bilirubin (mg/dl).
Model for end-stage liver disease (MELD) score = 9.57  loge creatinine mg/dl + 3.78  loge bilirubin mg/dl + 11.20  loge INR + 6.43.
The Glasgow AH score ranges from 5 to 12. The score given for each item is as follows: Age: 1 if <50 years or 2 ifP50 years; WCC (109/L): 1 if <15 or 2 ifP15; Urea (mmol/L)
1 if <5 or 2 if P5; PT ratio (expressed as a ratio of the control value): 1 if <1.5 or 2 if 1.5–2 or 3 if >2; Bilirubin (lmol/L): 1 if <125 or 2 if 125–250 or 3 if >250.
R Lille model (R) = 3.19–0.101  Age (years) + 0.147  albumin (g/L) + 0.0165  evolution in bilirubin (lmol/L)  0.206  (renal insufﬁciency)  0.0065  bilirubin day 0
(lmol/L)  0.0096  prothrombin time (seconds). Renal insufﬁciency is rated 0 if absent and 1 if present.
The Lille score ranges from 0 to 1 using the following formula: Exp (R)/(1 + Exp(R)).
The formulae of the Lille, DF and MELD scores are available online at http://www.lillemodel.com or www.mayoclinic.org/meld/mayomodel7.html.
* WCC = white cell count; NA = not applicable.
** Evolution in bilirubin in the Lille model = difference in bilirubin levels between day 0 and day 7 of corticosteroid treatment.
Frontiers in Liver Transplantation32 or more a similar score using the MELD or Glasgow alcoholic
hepatitis scores. Furthermore, Mathurin and his colleagues have
shown that the initial clinical response to prednisolone allows a
further reﬁnement in judging prognosis [4]. At ﬁrst, they relied
on a reduction in total bilirubin after 7 days of treatment. More
recently, they developed a composite score, which is called the
Lille model, that incorporates the change in total bilirubin on
day 7, plus additional clinical parameters (see Table 1) [5]. The
calculation of the Lille score stratiﬁes patients into those who
would respond to a 28-day course of prednisolone from those
who would not. Using the Lille score, 60% of their cohort were
responders, in whom the 6-month survival was 85%, compared
to the 40% of subjects who were non-responders, in whom the
6-month survival was 25%.
The present paper addresses the proposition that liver trans-
plantation should be considered for patients with severe alco-
holic hepatitis who are treatment non-responders and who
meet the other requirements for selection for liver transplanta-
tion, since their prognosis for survival is woeful. We will examine
the arguments in favour of and against liver transplantation in
this particular subset of patients with alcoholic hepatitis. We
would like to emphasise that we are not addressing all the ele-
ments of evaluation for liver transplantation, merely the issues
speciﬁc to a severe alcoholic hepatitis that is not responsive to
all appropriate therapy. It is important to note, however, that
the pre-transplant evaluation of patients with alcoholic liver dis-
ease should include screening for cancerous and pre-cancerous
lesions involving the oral cavity and pharynx, as well as bronchial
and oesophageal cancers, all of which are frequently associated
with alcohol or tobacco use.
The argument
Liver transplantation of patients with severe alcoholic hepatitis who
have failed conventional therapy is likely to improve patient
survival.
The main limitation to making an evidence-based argument
for liver transplantation in patients with severe alcoholic hepati-
tis unresponsive to prednisolone, is the absence of good data. In
general, patients with alcoholic hepatitis have been excluded
from access to the transplant waiting list on account of an insuf-
ﬁcient period of abstinence. By and large, an interval of 6 months
since the last drink has been applied to all alcoholic candidates in
published series, and this confounds the published and available760 Journal of Hepatology 201datasets. Furthermore, in most studies, alcoholic hepatitis has not
been identiﬁed as such and cannot be distinguished in the dataset
from decompensated alcoholic cirrhosis, sometimes referred to as
acute on chronic liver failure. When large databases, such as the
UNOS national database in the US, have been reviewed, and all
alcoholic liver disease patients have been considered en masse,
the diagnosis of alcoholic liver disease does not confer a worse
outcome in survival, either before or after transplantation, com-
pared to the remainder of the cohort [6]. This is in marked con-
trast to chronic hepatitis C infection, which reduces survival
both before and after liver transplantation, compared to patients
who are placed on the waiting list for other forms of liver disease.
Indeed, the reduction of post-transplantation survival is so
marked in the HCV-infected group that the survival beneﬁt,
judged from the time of placement on the waiting list for
patients with HCV is less than that for patients with alcoholic
liver disease [6].
There are no prospective studies of liver transplantation as a
rescue strategy after the failure of appropriate medical therapy
in patients with severe alcoholic hepatitis. Two studies have ret-
rospectively used the pathology of the explanted liver to label,
post hoc, some patients as having alcoholic hepatitis [7,8]. In
each study, one from Spain and one from our own unit in Wis-
consin, patient and graft survival was similar in patients with
the histologic markers of alcoholic hepatitis compared to the
alcoholic patients lacking features of hepatitis. These studies
are limited by retrospective biases, as well as by uncertainty
about whether histologic features such as Mallory bodies, stea-
tosis, and ballooned hepatocytes might persist even when the
patients have abstained from alcohol for six or more months.
In other words, we do not know if the patients were less than
truthful about their duration of abstinence or whether the his-
tologic syndrome of alcoholic hepatitis outlasts the clinical
syndrome.
Counterargument #1
Liver transplantation is not efﬁcacious in treating severe alcoholic
hepatitis.
The counterargument #1 recalls an earlier argument stating
that transplantation was inappropriate for anyone with alcoholic
liver disease because it was ineffective [9]. That assertion was
based on early experience and was not conﬁrmed by subsequent
data.0 vol. 52 j 759–764
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Given that thepopulationweare considering has failedmedical
therapy, either after 28-days prednisolone or after 7-days of pred-
nisolone and application of the Lille score, we know that this is a
group inwhom only 25%will be alive in 6 months. Because by def-
inition thesepatientshaveveryhigh total bilirubin levels andcoag-
ulopathy, and often an associated hepatorenal syndrome, their
MELD scores will be extremely high. Additionally, these patients
are likely (in the US allocation system at least) to rank at the top
of the transplant waiting list and therefore not to have to survive
through an extended period on the waiting list. The question,
therefore, is whether their 6-month survival after placement on
the waiting list would be signiﬁcantly better than 25%.
The main impediment to providing an answer to this question
is the lack of good prospective data. The syndrome of alcoholic
hepatitis implies recent alcohol consumption, thus historically
these patients have been excluded from consideration of liver
transplantation due to the ‘6-month rule’ [10]. Up to recently,
studies evaluating the outcome of liver transplantation in acute
alcoholic hepatitis, published in peer-reviewed journals, have
been limited to small case series and results from the transplan-
tation of patients with alcoholic cirrhosis. We have already made
reference to studies that examined the histopathological features
of alcoholic hepatitis in the explanted liver [7,8]. These analyses
indicated that the presence of histological alcoholic hepatitis
did not confer a worse outcome following transplantation com-
pared to alcoholic patients lacking these features. Nonetheless,
these studies are hampered by their retrospective nature and
the detachment between the clinical syndrome of alcoholic hep-
atitis and the histopathological features, which may persist for
several months despite the resolution of the clinical syndrome.
A small case series by Shakil et al. [11] evaluated the post-trans-
plant outcomes of 9 patients transplanted with alcoholic cirrho-
sis, in whom the authors made the diagnosis of severe alcoholic
hepatitis after the transplantation. All patients met criteria for a
Maddrey DF > 32. While patient survival was similar to that of
patients transplanted with alcoholic cirrhosis alone, these data
are compromised by retrospection and small numbers.
In 2005, a French Consensus Conference advocated therapeu-
tic trials of liver transplantation in patients with severe acute
alcoholic hepatitis who have failed to respond to medical treat-
ment, regardless of the brevity of the period of their abstinence
[12]. In response, Mathurin and his colleagues conducted a
case-control study of early transplantation in a highly selective
group of patients with severe alcoholic hepatitis who had failed
to respond to medical therapy. The ﬁrst report of this study
was presented at the annual meeting of the American Association
for the Study of Liver Diseases in November 2009, in Boston [13].
In this study, 18 patients with severe alcoholic hepatitis, who met
strict psychosocial requirements, underwent early liver trans-
plantation, occurring within 9 days of listing from their ﬁrst epi-
sode of hepatic decompensation. Each patient was paired to one
non-transplanted patient, also unresponsive to medical therapy,
who was matched for age, sex, and severity of liver disease as
assessed by DF and the Lille score. At 6 months, there was an
83.3% survival rate amongst the early transplanted group, com-
pared to 44.4% in the control group. The majority of the deaths
in the non-transplanted control group occurred within the ﬁrst
2 months of presentation. Further, there was no relapse to alcohol
use in the ﬁrst year amongst the early transplanted group. The
only relapse reported occurred at 917 days, where the patient
admitted to consuming one unit of alcohol three times a week.Journal of Hepatology 201These ﬁndings support the role of liver transplantation in the
select few patients with severe alcoholic hepatitis who are unre-
sponsive to medical therapy and unlikely to survive to complete a
6-month abstinence period and who are otherwise deemed suit-
able candidates from psychosocial and medical standpoints [13].
Resolution of the argument/counterargument
Given the exceedingly poor 6-month survival in the patient group
we have identiﬁed, it is highly likely that liver transplantation
will offer substantial improvements in survival at 6 months,
and we would estimate this to also hold true at 5 years. There-
fore, sustaining a position precluding this group from timely
transplantation must rest on other considerations such as likeli-
hood of spontaneous recovery (counterargument #2 below), the
risk of alcoholic relapse (counterargument #3 below), the effect
on society of transplantation of alcoholic hepatitics (counterargu-
ment #4 below), or the notion of personal responsibility for alco-
holism (counterargument #5 below).
Counterargument #2
Liver transplantation should not be considered in the treatment of
patients with severe alcoholic hepatitis, since many of these patients
are likely to recover without transplantation.
This is an important proposition, since it directly addresses
the impact of the 6-month rule [10]. It is clear that many patients
with alcoholic liver disease, including patients with alcoholic
hepatitis, will recover when they establish abstinence. The key
to understanding this counterargument lies in deﬁning the group
under discussion. Data from both modelling studies and in a ran-
domised controlled trial have shown that on account of the prev-
alence of recovery in the non-transplanted control group, liver
transplantation does not result in a gain in post-transplant sur-
vival in alcoholic patients with compensated (Childs class A or
B) cirrhosis [14,15]. In recognition of these observations, we have
speciﬁcally targeted patients with severe alcoholic hepatitis who
have failed to respond to medical management.
Rebuttal of counterargument #2
By limiting the discussion to the subset of patients with alcoholic
hepatitis who have failed treatment, we have already withdrawn
from consideration the patients likely to beneﬁt from more
extended periods of medical management and abstinence from
alcohol.
Counterargument #3
Liver transplantation should not be considered in treatment of
patients with severe alcoholic hepatitis, since many of these patients
are likely to relapse to addictive drinking.
Alcoholism is a disorder of remission and relapse, and some
recurrence of drinking by alcoholics who have undergone liver
transplantation is to be expected, no matter how stringent the
selection process. What about drinking after transplantation for
alcoholic hepatitis? Since there is a paucity of data on liver trans-
plantation in alcoholic hepatitis, we need to use the available
data on drinking behaviour by patients with alcoholic liver dis-0 vol. 52 j 759–764 761
Table 2. Prognostic factors for increased risk of relapse.
Prognostic Factors
for Increased
Risk of Relapse
Lack of insight 
 into addiction
Psychiatric co-morbid conditions
(including uncontrolled polysubstance abuse
           or unstable character disorder)
History of many failed 
rehabilitation attempts
Social isolation
(lack of employment, no fixed abode, 
living alone, no spouse or companion)
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ease in general, and those after liver transplantation in particular,
as a guide to answering this question. Unfortunately, this body of
literature is ﬁlled with biases and inaccuracies. First, there is the
difﬁculty of getting an accurate account of drinking, when
patients know that it may not be in their best interests to be can-
did [16]. Most studies are retrospective, contain a small number
of subjects, and are of short duration.
Abstinent patients with alcoholic cirrhosis often resume drink-
ing, even after a life-threatening decompensation or liver trans-
plantation. Here are three studies that indicate the degree to
which the urge to drink persists despite a life-threatening risk.
In a retrospective analysis of 5-year follow-up data gathered pro-
spectively in a trial of TIPS versus distal splenorenal shunt therapy
for cirrhotic patients who had experienced at least one episode
of variceal haemorrhage, heavy drinking (>4 drinks/day) was
recorded in 25 of 70 patients with alcoholic cirrhosis compared to
0 of 70 non-ALD subjects [17]. Similarly, in unpublished studies,
Weinrieb et al. found that approximately 25% of alcoholic patients
awaiting transplantation admitted to drinking, when they were
given the opportunity to answer without jeopardising their
chances of transplantation [18]. Veldt et al. prospectively studied
74 alcoholic cirrhotic patients whowere admitted to an in-patient
liver unit in France following decompensation due to recent
alcohol use [19]. Although 7 out of 13 patients with alcoholic
hepatitis recovered with medical management, alcohol use in
the follow-up period was an independent predictor of mortality
in the cohort as a whole. Therefore, it would be foolish to suggest
that no alcoholic hepatitis patients who are listed for or who pro-
ceed to transplantation will return to alcohol.
DiMartini et al.’s prospective, longitudinal, observational
study of 167 consecutive alcoholic liver transplant recipients pro-
vides the best data on drinking by alcoholics after transplantation
[20]. All subjects in DiMartini’s cohort received extensive pre-
transplant psychosocial evaluation, and only four recipients had
a recorded sobriety of less than 6 months. Five years after trans-
plantation, 42% of the alcoholic recipients had used alcohol at
least once, and the ﬁrst drink occurred in the ﬁrst year in 22%.
Furthermore, 26% had drunk in binges, and 22% had drunk on
four consecutive days.
While there are anecdotal reports of graft failure due to
relapse into addictive drinking [21], once again, there is a paucity
of good data on the impact of alcohol use on graft or patient sur-
vival after liver transplantation. Five-year patient and allograft
survival is similar in alcoholics and non-alcoholic liver transplant
recipients. However, a retrospective review of 10-year data from
a single large European centre indicated that relapse to addictive
or harmful drinking, as opposed to abstinence or abstinence with
occasional slips, was associated with increased mortality [22]. In
addition, there are reports of extrahepatic injury, such as pneu-
monia, delirium tremens, pancreatitis and gastritis, occurring in
association with drinking binges [23]. These observations, which
are in alcoholic patients in general rather than in those with
hepatitis, nevertheless beg the question as to whether a reduced
survival at 10 years or a greater frequency of alcohol-related
extrahepatic injuries should be considered sufﬁcient justiﬁcation
to deny transplantation.
Rebuttal of counterargument #3
Even if it is accurate to state that many of the alcoholic hepatitis
patients are likely to relapse to addictive drinking, this is an insufﬁ-762 Journal of Hepatology 201cient reason to deny life-saving therapy, particularly on the basis of
the ‘6-month abstinence rule’.
As mentioned in the foregoing, the best prospective data on
alcohol use after liver transplantation come from DiMartini and
colleagues. Since their study was undertaken with use of the 6-
month rule, we should assume that it excluded patients with clin-
ical alcoholic hepatitis. When their data were assessed regarding
whether there was a speciﬁc sobriety threshold greater than
6 months thatwould predict relapse, they found that, while longer
sobriety was associated with a lesser likelihood of drinking, even
3 years of abstinence was a poor predictor, which is similar to the
conclusionof Vaillant in his longitudinal study of drinkingpatterns
in alcoholic men [24]. Most patients with alcoholic hepatitis were
drinking up to the day of admission to the hospital, although the
clinical syndrome may be observed up to 1 month after the last
drink. We conclude that no short-term interval of sobriety (1, 3,
6 months) is a sufﬁciently accurate predictor of the risk of post-
transplant relapse in the alcoholic hepatitis patient. We advocate
a careful evaluationby anaddiction specialist, assessing the factors
shown in Table 2, as the best assessment of the prognosis for absti-
nence after transplantation [25].Resolution of the argument/counterargument #3
We agree that patients with alcoholic hepatitis are at high risk of
post-transplant alcoholic relapse. Furthermore, the resumption
of addictive drinking is associated with occasional instances of
acute liver failure, acute medical complications of alcohol excess,
and a possible reduction in graft survival between 5 and 10 years
after transplantation. With our present data, the 6-month rule is
an inappropriate instrument in patients with alcoholic hepatitis,
since all patientswill be excluded by its use.Whether reduced sur-
vivalmany years after transplantation in the subsetwho relapse to
addictive drinking justiﬁes withholding liver transplantation from
all patients with alcoholic hepatitis is the issue.Counterargument #4
Liver transplantation should not be considered in the treatment of
patients with severe alcoholic hepatitis, since many of these patients0 vol. 52 j 759–764
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are likely to relapse to addictive drinking, which is a breach of the
implicit compact between the transplant centres and society.
Liver transplantation is dependent on the generosity of the
public. Surveys of public opinion show that alcoholic candidates
are viewed as less compelling than patients with other diagnoses
[26]. This attitude to patients with alcoholic liver disease is most
likely a manifestation of the view that alcoholism is a personal
responsibility (counterargument #5 below). Nor do we gainsay
the risk that the public might withdraw support for liver trans-
plantation, and in particular decline to donate cadaveric organs,
thereby injuring the common good. In addition to the furore gen-
erated whenever a celebrity liver transplant recipient relapses to
alcohol use, we have learned from our own transplant program of
the negative impact of a drinking relapse on the transplant team.
It is demoralising for the transplant coordinators, social workers,
and nurses in the transplant program when an alcoholic patient
resumes drinking.
Counterargument #5
Liver transplantation should not be considered in the treatment of
patients with severe alcoholic hepatitis, since they have a self-
inﬂicted condition, for which they need to be held personally
accountable.Rebuttal of counterarguments #4 and #5
Counterarguments #4 and #5 operate on the basis of double
standards [27]. There are several severe medical illnesses that
are directly related to patient behaviour, for which patients con-
tinue to receive costly medical care without hesitation or contro-
versy amongst the medical community. Examples in the ﬁeld of
liver transplantation include chronic hepatitis B or C viral infec-
tion consequent on intravenous drug use. A more extreme view
would include patients with cirrhosis due to non-alcoholic fatty
liver disease in association with morbid obesity. The resources
needed to provide these medical services to these patients are
also precious and ﬁnite. Yet, heretofore, rationing care on the
basis of patient responsibility or lack of sympathy in the general
public has not been considered ethical. We would argue that pub-
lic sympathy should not be a criterion for allocation of public rev-
enue, as it would run risk of discriminatory biases based on race,
age, religion, or sexual orientation. We realise that continued
addictive behaviour raises profound questions about volition
and compulsion, temptation and gratiﬁcation, promises made
and broken. Counterargument #5 challenges the prevailing
model of addiction as a disease process. Furthermore, one may
ask why patients with severe alcoholic hepatitis should be sin-
gled out. If this rule were applied consistently, we should exclude
all patients with alcoholic liver disease, and many HCV patients
as well.A position of compromise
Liver transplantation is a treatment of last resort that uses
scarce resources. When considering liver transplantation with
an organ from a deceased donor, the transplant community is
sensitive to the need to husband these resources, balancing
the ethical concepts of justice and utility with the outcomeJournal of Hepatology 201measures. Severe alcoholic hepatitis presents the transplant
community with several challenges, compounded by the lack
of good data on the outcome of transplantation amongst these
candidates. Nevertheless, in our view, there is a place for liver
transplantation in a small subset of patients with severe alco-
holic hepatitis.
Although most patients with alcoholic liver disease experi-
ence positive outcomes following liver transplantation, all avail-
able data indicate that the desire to drink remains strong in some
alcoholic patients undergoing evaluation or following transplan-
tation. We cannot guarantee that patients with alcoholic hepatitis
will not resume alcohol use after transplantation. Predicting
which patients with severe alcoholic hepatitis will maintain
sobriety is especially difﬁcult. The decision to offer liver trans-
plantation to a patient with severe alcoholic hepatitis should be
made using a multi-disciplinary approach, on a case-by-case
basis. Since the 6-months abstinence rule is arbitrary, and likely
to preclude all patients with severe alcoholic hepatitis, we pro-
pose that liver transplantation should be a rescue option for occa-
sional patients who meet the following criteria. We would limit
liver transplantation to those patients with severe alcoholic hep-
atitis who are unlikely to survive a mandatory 6-month absti-
nence period, who have failed medical management, who
meet all other standard criteria for transplantation, and who
are deemed appropriate candidates following a thorough psycho-
social assessment. Since pre-transplant evaluation may reveal
problems that may preclude liver transplantation, such as dis-
seminated infection, cardiomyopathy, organic brain disease, mal-
nutrition or poor psychosocial assessment, implying a high risk
for relapse or poor compliance, the numbers of patients at a sin-
gle transplant centre fulﬁlling these entry criteria will be small.
Therefore, we recommend establishing an international database
to collect outcome data, including information on addictive
behaviour. That way, when we review this topic in another 5–
10 years, we will have more facts and less conjecture in future
discussions of the place of liver transplantation in the treatment
of alcoholic hepatitis.Key points
 At this time, patients with the severest forms of alcoholic hep-
atitis who have failed medical management have not been
offered liver transplantation, despite a very high short-term
mortality.
 Although largely unproven, it is very likely that liver transplan-
tation will offer, in this highly selected subset of patients, sub-
stantial improvements in the 6-month and 5-year patient
survivals.
 Reasons to deny transplantation to this population rest on
considerations such as the likelihood of spontaneous recov-
ery, the risk of alcoholic relapse while the patient is awaiting
or recovering from transplantation, the potential negative
effect of transplantation of alcoholic hepatitics on donation
of deceased liver allografts, or the notion of personal respon-
sibility for alcoholism.
 The present paper addresses the arguments and counterar-
guments that liver transplantation should be considered
for a carefully selected subset of patients with severe
alcoholic hepatitis who are treatment non-responders and
who meet the other requirements for selection for liver
transplantation.0 vol. 52 j 759–764 763
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